GOLDMAN SACHS GROUP INC - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 121 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.08 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$884,000
+0.8%
605,241
-2.0%
0.00%
Q4 2016$877,000
+24.2%
617,881
+53.1%
0.00%
Q3 2016$706,000
-13.8%
403,467
-15.8%
0.00%
Q2 2016$819,000
+31.5%
478,925
+51.3%
0.00%
Q1 2016$623,000
-75.7%
316,443
-76.5%
0.00%
-100.0%
Q4 2015$2,561,000
-12.7%
1,347,802
-12.3%
0.00%0.0%
Q3 2015$2,934,000
-60.0%
1,536,241
-2.9%
0.00%
-50.0%
Q2 2015$7,339,000
+18.6%
1,581,849
+11.7%
0.00%0.0%
Q1 2015$6,188,000
+11.1%
1,415,759
-11.8%
0.00%
+100.0%
Q4 2014$5,571,000
-22.8%
1,605,664
-6.7%
0.00%
-50.0%
Q3 2014$7,214,000
-8.1%
1,721,798
+28.5%
0.00%0.0%
Q2 2014$7,852,000
-30.5%
1,339,864
-25.3%
0.00%
-50.0%
Q1 2014$11,300,000
+149.7%
1,793,662
+131.9%
0.00%
+300.0%
Q4 2013$4,525,000
-5.2%
773,604
-14.6%
0.00%0.0%
Q3 2013$4,773,000
-58.9%
905,716
-39.9%
0.00%
-75.0%
Q2 2013$11,605,000
-7.2%
1,507,095
+8.7%
0.00%
-20.0%
Q4 2012$12,506,000
+19.0%
1,386,575
+9.8%
0.01%
+25.0%
Q3 2012$10,510,000
-24.0%
1,263,195
-8.9%
0.00%
-42.9%
Q2 2012$13,831,000
+2369.8%
1,386,517
+661.7%
0.01%
Q1 2012$560,000182,0270.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 1,281,400$6,753,0003.37%
Perceptive Advisors 5,116,200$26,962,0001.11%
SAMLYN CAPITAL, LLC 2,266,565$11,945,0000.33%
Tradeworx Inc. 132,839$700,0000.32%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,216,579$6,411,0000.30%
Lyons Wealth Management, LLC. 56,775$299,0000.27%
DIALECTIC CAPITAL MANAGEMENT, LP 125,000$659,0000.15%
Schonfeld Group Holdings LLC 11,400$60,0000.12%
DIALECTIC CAPITAL MANAGEMENT, LP 70,000$369,0000.08%
ELLINGTON MANAGEMENT GROUP LLC 72,000$379,0000.07%
View complete list of ARENA PHARMACEUTICALS INC shareholders